These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3022366)

  • 1. [Dopaminergic receptors].
    Piccinin GL; Piccirilli M; D'Alessandro P; Valle E; Sanarelli L
    Riv Neurol; 1986; 56(2):121-9. PubMed ID: 3022366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two distinct serotonin receptors in the mammalian central nervous system].
    Ye WL
    Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):110-4. PubMed ID: 3892666
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of dopamine in the pathogenesis of hypertension.
    Jose PA; Eisner GM; Felder RA
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation].
    Raevskiĭ KS; Sotnikova TD; Gaĭnetdinov RR
    Usp Fiziol Nauk; 1996; 27(4):3-29. PubMed ID: 9019922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural and functional organization of the cerebral dopaminergic system].
    Barishpolets VV; Fedotova IuO; Sapronov NS
    Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic receptors: a new antihypertensive mechanism.
    Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R
    J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbances in neurotransmission processes in aging and age-related diseases.
    Ossowska K
    Pol J Pharmacol; 1993; 45(2):109-31. PubMed ID: 8401765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future directions in dopaminergic nervous system and dopaminergic agonists.
    Cannon JG; Long JP; Bhatnagar R
    J Med Chem; 1981 Oct; 24(10):1113-8. PubMed ID: 7035666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of excitatory cholinergic synaptic transmission by Drosophila dopamine D1-like receptors.
    Yuan N; Lee D
    Eur J Neurosci; 2007 Nov; 26(9):2417-27. PubMed ID: 17986026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central synaptic transmitters.
    Curtis DR
    Proc Aust Assoc Neurol; 1970; 7():55-9. PubMed ID: 4328430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dopaminergic systems and their targets].
    Tassin JP
    Encephale; 1989; 15 Spec No():63-72. PubMed ID: 2663448
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interrelationship of the tranquilizers diazepam and lonetil with dopamine mediation in the central nervous system].
    Ovcharov R; Danchev N
    Eksp Med Morfol; 1981; 20(2):88-96. PubMed ID: 7250025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal modulation of central dopaminergic transmission.
    Drago F; Scapagnini U
    J Neural Transm Suppl; 1986; 22():47-54. PubMed ID: 3023550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
    Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of rudotel on the synaptic activity of dopaminergic neurons].
    Podgornaia EK; Galkina OV; Il'iuchenok RIu; Poliakov OV
    Eksp Klin Farmakol; 1998; 61(4):10-1. PubMed ID: 9783098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic actions of kainate receptors in the CNS.
    Rodríguez-Moreno A; Sihra TS
    J Neurochem; 2007 Dec; 103(6):2121-35. PubMed ID: 18070252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.